Non-Hormonal Menopause Treatment: What Actually Works

The short answer: if you cannot take hormone therapy, after a hormone-sensitive breast cancer, for example, or you prefer not to, there are real, evidence-based options that reduce hot flashes (hot flushes), night sweats and the sleep and mood fallout that come with them. The best-supported non-hormonal menopause treatments are certain antidepressants (SSRIs and SNRIs such as venlafaxine, paroxetine and escitalopram), the newer drug fezolinetant (Veoza) that targets the brain circuit behind flushes directly, and cognitive behavioural therapy, which has strong evidence for flushes, sleep and mood. Gabapentin, clonidine and oxybutynin help some women, and lifestyle changes support all of the above. None is a perfect substitute for oestrogen, but several work well enough to change how you feel.

If you have searched “what can I take if I can’t have HRT” or landed here after being told hormones are off the table, you are asking a question thousands of women ask, and it has better answers than it used to. Being unable to take hormone replacement therapy, or choosing not to, does not mean living with symptoms untreated. The Menopause Society 2023 nonhormone position statement reviewed the evidence and named several options as effective. This guide walks through what each one does, how strong the evidence is, and where the honest limits are.

Why might I need a non-hormonal option?

The most common reason is a personal or family history of a hormone-sensitive cancer, breast cancer above all. If a tumour was fuelled by oestrogen, adding oestrogen back carries a risk most oncologists will not accept, and drugs like tamoxifen or aromatase inhibitors can worsen flushes at the same time. Other reasons include a history of certain blood clots, some liver conditions, or medications that interact badly with hormones.

And many women prefer not to take hormones, for reasons that are theirs to hold. Whatever the route in, the goal is the same: to treat the symptoms that are disrupting your life without using systemic oestrogen. It helps to be clear on terms first. “Non-hormonal” here means treatments that do not add oestrogen or progesterone to your body, so they work through the brain, the nervous system or your daily habits rather than by replacing the hormone you have lost.

Which antidepressants help hot flashes, and how well?

This is the option most women are offered first, and the evidence behind it is solid. Certain SSRIs and SNRIs reduce the frequency and severity of hot flashes even at doses lower than those used for depression, and they can lift the low mood and anxiety that often travel with the menopause transition. Paroxetine is the only one specifically approved in the US for hot flashes at a low dose, but venlafaxine, escitalopram and desvenlafaxine all have good supporting evidence and are widely used.

Expect a meaningful reduction rather than elimination: trials typically show flushes cut by roughly a third to a half, not switched off. One important caution: paroxetine and fluoxetine can interfere with tamoxifen, so women taking tamoxifen after breast cancer are usually steered towards venlafaxine or another option their oncologist approves. Side effects such as nausea, dry mouth or altered sleep are common at first and often settle. Some women also find the effect fades over months, which is worth flagging to your practitioner rather than quietly giving up.

What is fezolinetant (Veoza), and is it worth asking about?

Fezolinetant is the newest real development in this field for a long time. It is a neurokinin-3 receptor antagonist, which means it acts directly on the brain circuit in the hypothalamus that goes haywire when oestrogen falls and misfires your temperature control, the mechanism behind a hot flash. It does this without touching hormone levels at all. The FDA approved it in 2023 and the MHRA and EMA followed in 2024, licensed specifically for moderate to severe vasomotor symptoms.

In its trials it reduced moderate-to-severe flushes by around half or more, and many women notice a difference within the first weeks. The honest caveats matter here. It treats flushes and night sweats, not the full range of menopause symptoms, and it is not a substitute for local treatment of vaginal symptoms. It also carries a warning about rare liver injury, so practitioners run blood tests before starting and periodically afterwards. For a woman who cannot take hormones and whose main problem is flushing, it is a strong option to raise. Availability and cost still vary by country.

The options at a glance

Because the choice depends on which symptoms trouble you most and what else is going on in your health, it helps to see the main non-hormonal treatments side by side, with an honest read on how strong the evidence is and what each one helps.

Does CBT really work for hot flashes?

It does, and this surprises people who assume talking therapy only touches mood. Cognitive behavioural therapy has some of the strongest evidence of any non-drug approach for the menopause transition. It does not necessarily reduce how many flushes you have, but it reliably reduces how much they bother you and how disruptive they feel, and it improves sleep and low mood at the same time. NICE guideline NG23 explicitly notes CBT as an option for menopausal symptoms including low mood and anxiety.

The mechanism is not mysterious. A hot flash triggers a cascade of thoughts and physical tension that amplifies the experience, and CBT gives you practical tools to interrupt that loop, alongside sleep and stress techniques. Structured menopause-specific CBT programmes exist, some delivered in groups or self-guided online, which makes it more accessible than a course of one-to-one therapy. It carries no drug interactions, which makes it especially useful after breast cancer, and it pairs well with any of the medications above rather than competing with them.

What about gabapentin, clonidine and oxybutynin?

These are the second-line prescription options, useful when the first choices are not tolerated or not enough. Gabapentin, borrowed from nerve-pain and seizure treatment, can reduce flushes and is worth considering for night-time sweats because its drowsiness side effect can help sleep. Oxybutynin, a bladder medication, has reasonable evidence for reducing hot flashes, though it can cause dry mouth and is used cautiously in older women.

Clonidine, an old blood-pressure drug, has been prescribed for flushes for years but its effect is modest and side effects like dry mouth, low blood pressure and drowsiness limit it, so it has slipped down the list as better options have arrived. All three are decisions to make with a practitioner who knows your full history, and none should be started or stopped abruptly. A wider look at what does and does not have evidence, including over-the-counter products, is in our guide to menopause supplements.

One important exception: vaginal oestrogen

There is a point of confusion worth clearing up, because it changes what is possible for many women. Systemic hormone therapy, the kind that treats whole-body symptoms, is what is usually avoided after a hormone-sensitive cancer. Local vaginal oestrogen is a different thing: a very low-dose cream, pessary or ring that treats vaginal dryness, discomfort and recurrent urinary symptoms with almost no absorption into the bloodstream.

Major bodies including The Menopause Society generally consider low-dose vaginal oestrogen safe even for many women who avoid systemic HRT, including many breast cancer survivors, though this is a decision to make with your oncologist rather than assume. It is worth knowing about because vaginal and urinary symptoms are common, persistent and rarely improve on their own, yet non-hormonal moisturisers and lubricants also help and are always an option. For the wider picture of how systemic hormone therapy differs from this, our explainer on what HRT involves sets it out.

The lifestyle levers that support everything else

No lifestyle change matches a well-chosen medication for severe flushes, and it is fair to be sceptical of advice that stops at “keep cool and cut caffeine” when you are drenched at 3am. But several habits have real, if modest, effects and make the treatments above work better. Keeping your environment and clothing cool, using layers and a fan, and cooling the bedroom reduce night sweats for many women.

Alcohol, caffeine and spicy food are common triggers worth testing by removing. Regular exercise supports sleep, mood and weight, and carrying less excess weight is linked to fewer flushes, though exercise in the moment does not stop a flush. Slow, paced breathing at the onset of a flush helps some women. None of this is a cure, and none should replace treatment you need, but together these levers lower the overall load and are entirely compatible with any of the medical options. Yellow can help you track which triggers matter for you and prepare for the conversation with your practitioner: you can start at spotyellow.com.

Frequently Asked Questions

What is the best non-hormonal treatment for hot flashes?

There is no single best option; it depends on your health and which symptoms trouble you most. The strongest-evidence choices are certain SSRIs or SNRIs, the newer drug fezolinetant, and cognitive behavioural therapy. Many women combine a medication for flushes with CBT for how flushes and sleep affect them.

Can I take anything for menopause after breast cancer?

Yes. Non-hormonal options are specifically designed for this situation. Venlafaxine, fezolinetant, CBT, gabapentin and lifestyle measures are all compatible with breast cancer treatment, though some antidepressants interact with tamoxifen. Low-dose vaginal oestrogen is often considered safe for local symptoms, but confirm every choice with your oncologist.

Do antidepressants for hot flashes mean I am depressed?

No. SSRIs and SNRIs act on brain pathways that also regulate temperature control, which is why low doses reduce flushes independently of any effect on mood. Being offered one for hot flashes is not a judgement about your mental health, though it is a useful bonus if low mood or anxiety are also present.

Is fezolinetant (Veoza) safe?

For most women it is well tolerated, with the main concern being rare liver injury, which is why practitioners run blood tests before and during treatment. It is licensed by the FDA (2023) and the MHRA and EMA (2024) for moderate to severe hot flashes and night sweats. It does not treat vaginal or other symptoms.

How well does CBT work for menopause symptoms?

Cognitive behavioural therapy has strong evidence, recognised in NICE guideline NG23. It does not necessarily reduce the number of flushes but reliably reduces how much they bother you, while improving sleep and low mood. It has no drug interactions, which makes it especially useful when medications are limited, and it works well alongside them.

Is vaginal oestrogen the same as HRT?

Not in practical terms. Systemic HRT treats whole-body symptoms and reaches the bloodstream; low-dose vaginal oestrogen is a local treatment for dryness and urinary symptoms with minimal absorption. It is generally viewed as much lower risk, and often acceptable even where systemic hormones are avoided, but this remains a decision to make with your specialist.

Further Reading

• The Menopause Society. 2023 nonhormone therapy position statement. https://menopause.org/patient-education/menopause-topics
• NICE. Menopause: diagnosis and management (NG23). https://www.nice.org.uk/guidance/ng23
• FDA. FDA approves novel drug to treat moderate to severe hot flashes caused by menopause. https://www.fda.gov/news-events/press-announcements
• Breast Cancer Now. Menopausal symptoms and breast cancer. https://breastcancernow.org/about-breast-cancer
• NHS. Menopause: things you can do and treatment. https://www.nhs.uk/conditions/menopause/

This article is for general information and does not constitute medical advice. Non-hormonal treatments have different risks, interactions and evidence levels, and the right choice depends on your personal medical history. This is especially true after breast cancer or other hormone-sensitive conditions. Please discuss any treatment with a qualified healthcare professional before starting or stopping it.